BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27110038)

  • 41. Inhibition of liver microsome-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in the rat following glucose administration.
    Vance RE; Teel RW; Strother A
    Cancer Lett; 1990 Apr; 50(2):149-56. PubMed ID: 2109652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benzo[a]pyrene and Caenorhabditis elegans: defining the genotoxic potential in an organism lacking the classical CYP1A1 pathway.
    Abbass M; Chen Y; Arlt VM; Stürzenbaum SR
    Arch Toxicol; 2021 Mar; 95(3):1055-1069. PubMed ID: 33420596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro mechanistic differences in benzo[a]pyrene-DNA adduct formation using fish liver and mussel digestive gland microsomal activating systems.
    Peters LD; Telli-Karakoç F; Hewer A; Phillips DH
    Mar Environ Res; 2002; 54(3-5):499-503. PubMed ID: 12408608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterologous expression of human cytochrome P450 2S1 in
    Mrízová I; Moserová M; Milichovský J; Šulc M; Kizek R; Kubáčková K; Arlt VM; Stiborová M
    Monatsh Chem; 2016; 147():881-888. PubMed ID: 27110039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
    Wroblewski VJ; Gessner T; Olson JR
    Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of and DNA adduct formation by benzo[alpha]pyrene in human skin epithelial cells in vitro pretreated with cytochrome P450 modulators.
    Lehman TA; Kurian P; Milo GE
    Cancer Biochem Biophys; 1989 Oct; 10(4):345-52. PubMed ID: 2515917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro.
    Devanesan PD; RamaKrishna NV; Todorovic R; Rogan EG; Cavalieri EL; Jeong H; Jankowiak R; Small GJ
    Chem Res Toxicol; 1992; 5(2):302-9. PubMed ID: 1643262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.
    Pastorelli R; Guanci M; Cerri A; Negri E; La Vecchia C; Fumagalli F; Mezzetti M; Cappelli R; Panigalli T; Fanelli R; Airoldi L
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):703-9. PubMed ID: 9718223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes.
    Wood AW; Levin W; Lu AY; Yagi H; Hernandez O; Jerina DM; Conney AH
    J Biol Chem; 1976 Aug; 251(16):4882-90. PubMed ID: 821945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of divalent cations on NADH-dependent and NADPH-dependent cytochrome b5 reduction by hepatic microsomes.
    Tamura M; Yoshida S; Tamura T; Saitoh T; Takeshita M
    Arch Biochem Biophys; 1990 Aug; 280(2):313-9. PubMed ID: 2369123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
    Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
    Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vanadate-dependent NAD(P)H oxidation by microsomal enzymes.
    Reif DW; Coulombe RA; Aust SD
    Arch Biochem Biophys; 1989 Apr; 270(1):137-43. PubMed ID: 2494940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depression of hepatic cytochrome P450 monooxygenases after chronic environmental tobacco smoke exposure of young ferrets.
    Sindhu RK; Rasmussen RE; Yamamoto R; Fujita I; Kikkawa Y
    Toxicol Lett; 1995 Apr; 76(3):227-38. PubMed ID: 7762009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
    Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of hepatic cytochrome P450 (P450) oxidoreductase deficiency on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct formation in P450 reductase conditional null mice.
    Arlt VM; Singh R; Stiborová M; Gamboa da Costa G; Frei E; Evans JD; Farmer PB; Wolf CR; Henderson CJ; Phillips DH
    Drug Metab Dispos; 2011 Dec; 39(12):2169-73. PubMed ID: 21940903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A monoclonal antibody to rat liver cytochrome P450 IIC11 strongly and regiospecifically inhibits constitutive benzo[a]pyrene metabolism and DNA binding.
    Todorovic R; Devanesan PD; Cavalieri EL; Rogan EG; Park SS; Gelboin HV
    Mol Carcinog; 1991; 4(4):308-14. PubMed ID: 1872951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase.
    Joseph P; Jaiswal AK
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8413-7. PubMed ID: 8078896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.
    Shimada T; Gillam EM; Oda Y; Tsumura F; Sutter TR; Guengerich FP; Inoue K
    Chem Res Toxicol; 1999 Jul; 12(7):623-9. PubMed ID: 10409402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.